Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -1,058.33%-49.45K | -93.71%-52.01K | -1,188.81%-245.58K | -107.29%-31.21K | -24,106.91%-192.69K | 202.73%5.16K | -1,575.11%-26.85K | -1,062.60%-19.06K | -15.06K | -796 |
| Net income from continuing operations | -30.21%-97.54K | -569.08%-89.83K | -393.27%-288.97K | -172.41%-119.63K | -10,259.85%-81.01K | -110,060.29%-74.91K | 2.85%-13.43K | -808.69%-58.58K | ---43.91K | ---782 |
| Change In working capital | -41.68%46.69K | 381.83%37.83K | 9.77%43.39K | 206.39%88.42K | -797,564.29%-111.67K | 1,715.92%80.07K | -185.81%-13.42K | 722.13%39.53K | --28.86K | ---14 |
| -Change in receivables | -151.27%-5.05K | -558.78%-4.43K | 11.00%-4.79K | -205.21%-3.17K | 8,238.46%1.06K | -4.47%-2.01K | 72.08%-672 | -341.15%-5.38K | ---1.04K | ---13 |
| -Change in prepaid assets | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 |
| -Change in payables and accrued expense | -36.96%51.75K | 431.41%42.25K | 7.28%48.18K | 240.91%91.58K | -11,273,000.00%-112.73K | --82.08K | -170.64%-12.75K | 645.02%44.91K | --26.86K | ---1 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -1,058.33%-49.45K | -93.71%-52.01K | -1,188.81%-245.58K | -107.29%-31.21K | -24,106.91%-192.69K | 202.73%5.16K | -1,575.11%-26.85K | -1,062.60%-19.06K | ---15.06K | ---796 |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 360.78%37.5K | -37.5K | 62.75%-24.38K | -167.01%-10K | 0 | 25.30%-14.38K | 0 | -67.44%-65.45K | 14.92K | -2.5K |
| Capital expenditure reported | 360.78%37.5K | ---37.5K | 62.75%-24.38K | -167.01%-10K | --0 | 25.30%-14.38K | --0 | -67.44%-65.45K | --14.92K | ---2.5K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 360.78%37.5K | ---37.5K | 62.75%-24.38K | -167.01%-10K | --0 | 25.30%-14.38K | --0 | -67.44%-65.45K | --14.92K | ---2.5K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 27.5K | 57.5K | 0 | 0 | 0 | 0 | 0 | 162.13%327.66K | 300K | 0 |
| Net issuance payments of debt | --65K | --20K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net common stock issuance | ---- | --37.5K | --0 | --0 | ---- | ---- | --0 | 140.00%300K | --312.64K | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --30.3K | ---10K | --10K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---2.64K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --27.5K | --57.5K | --0 | --0 | --0 | --0 | --0 | 162.13%327.66K | --300K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -91.53%25.46K | -82.45%57.46K | 288.53%327.43K | 258.05%98.67K | 844.31%291.36K | 994.32%300.58K | 288.53%327.43K | --84.27K | --27.56K | --30.85K |
| Current changes in cash | 268.66%15.55K | -19.22%-32.01K | -211.03%-269.96K | -113.74%-41.21K | -5,746.09%-192.69K | -372.22%-9.22K | 52.74%-26.85K | 188.53%243.15K | --299.87K | ---3.3K |
| End cash Position | -85.93%41.01K | -91.53%25.46K | -82.45%57.46K | -82.45%57.46K | 258.05%98.67K | 844.31%291.36K | 994.32%300.58K | 288.53%327.43K | --327.43K | --27.56K |
| Free cash from | -29.61%-11.95K | -233.39%-89.51K | -219.46%-269.96K | -30,884.21%-41.21K | -5,746.09%-192.69K | 62.02%-9.22K | 52.74%-26.85K | -107.49%-84.51K | ---133 | ---3.3K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.